<DOC>
	<DOCNO>NCT00324766</DOCNO>
	<brief_summary>The purpose study determine safety efficacy 24 hour infusion levosimendan patient acute myocardial infarction heart failure acute percutaneous coronary intervention ( PCI ) treatment .</brief_summary>
	<brief_title>Levosimendan Acute Heart Failure Following Acute Myocardial Infarction .</brief_title>
	<detailed_description>Double blind placebo-controlled study parallel group patient acute PCI treat myocardial infarction complicate decompensated heart failure . The study include prospectively define subgroup patient cardiogenic shock . Treating acute myocardial infarction PCI restore blood flow , decreased contractility remain hour day due stun myocardium . Levosimendan inotropic vasodilatory effect could support fail heart treat acute myocardial infarction PCI may improve myocardial stun decrease pro-inflammatory cytokine . Levosimendan could improve myocardial contractility , symptoms outcome without adverse effect . The aim study investigate whether 24 hour infusion levosimendan could improve regional contractility measure echocardiography , improve BNP level , reduce level pro-inflammatory cytokine improve symptom patient acute decompensated heart failure first 24 hour acute PCI .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Shock , Cardiogenic</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<criteria>Acute STelevation myocardial infarction subject acute PCI nonST elevation myocardial infarction subject PCI within 72 hour start chest pain : Revascularization PCI , Signs decrease wallmotion least 3 16 segment leave ventricle Dyspnoea rest one following : pulmonary edema , pulmonary congestion , need CPAP ventilator , need IC diuretic oliguria . Subgroup patient cardiogenic shock : Systolic BP 90 1 hour volume therapy . Age 20 year Heart rate 120 bpm Septic shock ARDS Creatinine &gt; 450 micromol/l Hepatic impairment Significant mechanical outlet obstruction Allergy study drug medication Anaemia ( Hb &lt; 8 g/dl ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>